MedTrace Logo

Long-Covid: Treatment of Cognitive Difficulties

NCT05167266 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2024-07-09

No results posted yet for this study

Summary

The purpose of the study is to explore the potential effectiveness of two common low-dose interventions, one targeting cognitive difficulties and the other targeting affective difficulties on quality of life and cognition in people suffering from long-COVID with cognitive complaints.

Conditions

Interventions

BEHAVIORAL

Psychoeducation

Psychoeducation refers to the process of providing education and information to those seeking or receiving mental health services.

Sponsors & Collaborators

  • University Hospital, Antwerp

    collaborator OTHER

  • University of Liege

    lead OTHER

Principal Investigators

  • Sylvie Willems, PhD · ULiège

  • Fabienne Collette, PhD · ULiège

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-15
Primary Completion
2024-01-26
Completion
2024-07-02

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05167266 on ClinicalTrials.gov